Ajax-Loading

Eli Lilly and Company - Long Term Investments

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Long-Term-Investments" stands at 2.81 Billion United States Dollars as of 09/30/2025, the lowest value since 12/31/2023.

As of the end of Eli Lilly and Company's third quarter, the item "Long Term Investments" stands at 2.81 Billion USD. This represents a decrease of -12.44 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -12.25 percent compared to the value the year prior.
The 1 year change in percent is -12.25.
The 3 year change in percent is 9.08.
The 5 year change in percent is 13.41.

The Serie's long term average value is 3.44 Billion United States Dollars. It's latest available value, on 09/30/2025, is 18.45 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2010, to it's latest available value, on 09/30/2025, is +57.81%.
The Serie's change in percent from it's maximum value, on 03/31/2014, to it's latest available value, on 09/30/2025, is -61.02%.

Long Term Investments for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Long Term Investments486,508,953,600.00
LogoAbbVie Inc - Long Term Investments399,570,305,024.00
LogoRoche Holding AG - Long Term Investments317,433,206,677.55
LogoAstraZeneca PLC - Long Term Investments280,205,508,085.11
LogoNovartis AG - Long Term Investments255,096,620,580.91